CELSR2, FN1, SPARCL1, APOE, LPA, APOA5, and TGFB1 exhibit causal associations with both atherosclerosis and four cardiovascular diseases, suggesting their potential as therapeutic targets for atherosclerosis. This evidence concerns the gene TGFB1 and atherosclerosis.